Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4522061 | 1.00 | MEN1 (0.58) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL10026225 | 1.00 | MEN1 (0.58) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL823818 | 0.98 | MEN1 (0.54) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL13668048 | 0.90 | MEN1 (0.58) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL10026227 | 0.90 | MEN1 (0.77) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2288544 | 0.87 | TSHR (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL16609231 | 0.84 | MEN1 (0.75) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL5191031 | 0.84 | MEN1 (0.75) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL4433304 | 0.84 | MEN1 (0.75) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL12754637 | 0.84 | MEN1 (0.75) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090206245-A1 | Mass analysis method using fine metal particles | SHIONOGI CO., LTD (JP) | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090206245-A1 | Mass analysis method using fine metal particles | OSTC, ZKSCAN2, SLC17A5 | MEN1 670/4885KMT2A 2208/4885THRB 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.